Ten pre-doctoral researchers will be recruited.
AltraBio is participating in this initiative, which has 15 partners and aglobal budget of more than 2.6 million euros.
This project, called SIGNATURE (SInGle cells iN AuToimmUne inflammatoRy disEases), is part of the Marie Skłodowska-Curie Actions Programme and the Horizon Europe programme, the European Union’s R&D&I plan. This international network will train enterprising, innovative and resilient doctoral students, capable of facing current and future challenges and turning knowledge and ideas into products and services for economic and social benefit.
Specifically, and within the framework of this network, a ten pre-doctoral researchers will be recruited (including one at AltraBio) to follow a training programme in the consortium’s partner organisations. In this way, the doctoral students will be in contact with the academic and non-academic research sectors; receiving training related to research, innovation and long-term employability in the field of biomedical sciences. The participating researchers will have an international professional development plan supervised by the relevant scientists in each of the organisations participating in the network. More specifically, the pre-doctoral researcher recruited by AltraBio will 1) develop machine-learning-based analytical pipelines adapted to the analysis and integration of the data generated, or available to, the consortium (tissue images, single cell studies, clinical data) and 2) implement the develop methods to analyse the data generated by the consortium to define the molecular stratification of the diseases and to identify molecular predictors of treatment response.